SENZAGEN
Live / Registered — Registered (as of 03 Nov 2020)
What this means for you
Registered since 03 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79258436
- Registration number
- 6187125
- Mark type
- Stylized text
- Filed
- 17 Nov 2017
- Published for opposition
- 18 Aug 2020
- Registered
- 03 Nov 2020
- Attorney of record
- Bradley L. Cohn
Goods and services
- Class 001 — Chemicals: Diagnostic preparations for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; assays for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; diagnostic biomarkers for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; diagnostic preparations, assays and biomarkers for use in in vitro testing, assessment of toxicological properties of chemical compounds and mixtures, genomic analysis, assessment of chemical skin sensitizers, respiratory sensitizers and potency classification of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for scientific testing and screening purposes, performed in laboratories for scientific testing and screening purposes; diagnostic preparations, assays and biomarkers for screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes, for scientific testing and screening purposes, and not for medical or veterinary use
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical use; assays for medical use; diagnostic biomarkers for medical use; diagnostic preparations, assays and biomarkers for use in in vitro testing, assessment of toxicological properties of chemical compounds and mixtures, genomic analysis, assessment of chemical skin sensitizers, respiratory sensitizers and potency classification, all for medical testing and screening purposes; diagnostic preparations, assays and biomarkers for screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes in the medical and pharmaceutical industries, all for medical and pharmaceutical medical-based testing and screening purposes
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design in the field of genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification; scientific industrial analysis and research services in the field of genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification; scientific research and development; conducting research in the field of genomics and animal-free product testing; laboratory services in the field of genomics and animal-free product testing; in vitro analysis and dermal and respiratory analysis of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products for scientific, medical and pharmaceutical research purposes; assessment of toxicological properties of chemical compounds and mixtures, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro skin and respiratory sensitization analysis of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro safety assessments of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro testing for assessment of chemical skin sensitizers, respiratory sensitizers and potency classification for scientific, medical and pharmaceutical research services and for medical research and scientific research purposes; allergy analysis and animal-free allergy analysis of consumer products, chemical products, cosmetic products, pharmaceutical products and medical products for medical and pharmaceutical purposes; custom development of sensitization assays for prediction and classification of chemical sensitizers; safety and potency classification of chemicals, for medical, pharmaceutical and scientific research services; safety and potency testing of cosmetic ingredients; assessment of sensitizers for industry product testing and regulatory purposes in the medical and pharmaceutical industries; safety assessments of chemicals and proteins in the medical and pharmaceutical industries; in vitro product testing assessment of allergens, in the medical and pharmaceutical industries; sensitization product testing for the pharmaceutical, cosmetic and chemical industry; information, advisory and consultancy services relating to genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification, product testing assessment of toxicological properties of chemical compounds and mixtures for medical and pharmaceutical research purposes; animal-free product testing of chemical compounds, genomic product testing, animal-free genomic product testing, dermal and respiratory in vitro product testing and analysis, in vitro skin and respiratory sensitization product testing and analysis, in vitro product safety assessments, product testing and assessment of sensitizers, in vitro product testing for assessment of chemical skin sensitizers, respiratory sensitizers and potency classification, all for medical and pharmaceutical product safety purposes; screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes in the medical and pharmaceutical industries and for medical research and scientific research purposes; safety assessment of chemicals and proteins, in vitro assessment of allergens, all for medical and pharmaceutical purposes and for medical research and scientific research purposes; sensitization product testing for the pharmaceutical and cosmetic industries; in vitro safety and toxicity testing of medical devices
- Class 044 — Medical, beauty and agricultural services: In vitro testing for medical and pharmaceutical diagnostic purposes; allergy testing and animal-free allergy testing, all for medical and pharmaceutical diagnostic purposes; information, advisory and consultancy services relating thereto
Owner
- SenzaGen AB, SE
- SenzaGen AB, SE
- SenzaGen AB, SE
Prosecution history
- 03 Nov 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 02 Apr 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 29 Jan 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Mar 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 13 Feb 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 13 Feb 2021 — FINAL DISPOSITION PROCESSED
- 03 Feb 2021 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 03 Feb 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 03 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 08 Oct 2020 — ATTORNEY REVIEW COMPLETED
- 19 Aug 2020 — CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
- 18 Aug 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Aug 2020 — PUBLISHED FOR OPPOSITION
- 14 Aug 2020 — NOTIFICATION PROCESSED BY IB
- 29 Jul 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB